Ardian-backed Dedalus completed the acquisition of Dosing.

Ardian-backed Dedalus, a healthcare and diagnostic software provider, completed the acquisition of Dosing, a healthcare software services provider. Financial terms were not disclosed. "Dosing brings solutions and capabilities that are essential for the digital transformation of the healthcare ecosystem - the core of our vision. We believe that clinically relevant content, such as medication safety information, is central to ensuring the highest quality and safety of care through the Clinical Decision Support solutions within our portfolio," Andrea Fiumicelli, Dedalus CEO.